Overview

ESTIMATION OF THE EFFECT OF MULTIPLE DOSE PF-06651600 ON THE PHARMACOKINETICS OF SINGLE DOSE MIDAZOLAM AND EFAVIRENZ

Status:
Completed
Trial end date:
2019-02-21
Target enrollment:
Participant gender:
Summary
The current study will estimate any inhibitive or inductive effect of PF-06651600 on the pharmacokinetics of midazolam and efavirenz.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Efavirenz
Midazolam